Plain-English translation of NCT03217110 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing transcranial magnetic stimulation (TMS)—a non-invasive procedure that uses magnetic pulses to stimulate a part of your brain called the cerebellum. Researchers believe that stimulating this area might help restore normal brain rhythms and improve thinking, memory, and cognitive function in people with conditions like schizophrenia, autism, bipolar disorder, depression, or Parkinson's disease. The treatment has shown promise in early research, and this study will help determine if it actually works and is safe.
People with these conditions often have trouble with thinking, focus, and memory because certain brain regions don't communicate well. This treatment is being studied because it might help 'reset' those brain patterns and improve everyday cognitive abilities—offering a new option beyond current medications.
You likely qualify if…
You likely don't qualify if…
You will visit the research site 8–9 times over several weeks. During your first 5–6 visits, you will receive either real or sham (fake) magnetic stimulation twice a day for 5 days, along with cognitive and emotional testing. The researchers will use EEG (brain wave recording) and MRI (brain imaging) to measure changes in your brain activity and cognitive function. You will also return for 3 follow-up visits to see if any improvements last over time.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States